Pyrrolo[2,3-d]pyrimidines as inhibitors of pp60c-src

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 3, 1997-03 ,pp. : 271-273

Informa Healthcare

Access to resources Recommend Favorite

Captopril inhibits pp60 c-src tyrosine phosphorylation in cultured human mesangial cells

By Ruiz-Gines J.A.   Perez-Caballero C.   O'Valle F.   Rodrguez-Puyol M.   Rodrguez-Puyol D.  

European Journal of Pharmacology, Vol. 336, Iss. 2, 1997-10 ,pp. : 251-256

Elsevier

Access to resources Recommend Favorite

Novel Patented Src Kinase Inhibitor

By  

Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-04 ,pp. : 1821-1829

Bentham Science Publishers

Access to resources Recommend Favorite

N7-Substituted-5-aryl-pyrrolo[2,3-d]pyrimidines Represent a Versatile Class of Potent Inhibitors of the Tyrosine Kinase c-Src

By  

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-06 ,pp. : 201-208

Bentham Science Publishers

Access to resources Recommend Favorite

Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells

By Bouallegue Ali   Vardatsikos George   Srivastava Ashok K.  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 12, 2009-12 ,pp. : 1009-1018

NRC Research Press

Access to resources Recommend Favorite